Can booster jab nullify new Covid-19 threats?
Trials under way for a third vaccine shot for over-50s to eradicate danger from coronavirus variants
A third booster jab for Covid-19 could be offered to all over-50s in the autumn in an effort to drastically reduce the likelihood of another lockdown in the UK.
The extra shot might be given alongside annual flu vaccinations to those aged over 50 and the clinically vulnerable, according to The Times.
The newspaper reports that trials of two options are under way, supervised by the chief medical officer for England, Chris Whitty. Early findings have “raised government hopes” that the two approaches will “nullify any threat from new and existing variants” of Covid-19, which has already led to 150,000 deaths in the UK alone, The Times was told.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Trials under way
The first trial involves vaccines “specifically modified to tackle new variants”, reports the paper, while the second is for a third shot of one of the three jabs already in use: Pfizer-BioNTech, Oxford-AstraZeneca, or Moderna.
While the vaccines currently available successfully tackle the Kent variant, they offer weaker protection against other strains of the virus, such as the South African variant of the virus, says the paper.
A third jab could give recipients “a massive amount of new antibodies” which may be strong enough to stop the infection from new variants, say scientists. Recipients are likely to be given a third shot that is different from the make they originally received, as studies have found it is likely to be “stronger” if another jab is administered.
The Department of Health has ordered 60 million Pfizer jabs to be used as booster jabs, in preparation for the programme, which will take roughly 11 weeks to complete.
The two methods are currently being evaluated, but “could be rolled out simultaneously if they are judged to be equally effective”, says the Times.
Virus will ‘fade into the background’
An unnamed senior government minister said the trials were “looking really positive so far”, and brought hopes that the level of protection against Covid-19 variants will be “so high” by Christmas that the deadly illness will have “just faded away into the background like any other illness in circulation”.
“So much so that we don’t think there will be any need to give a booster shot to younger people because transmission will have got so low,” the minister added.
Vaccines Minister Nadhim Zahawi said the UK would be made “future proof” against new variants of the virus, thanks to a multimillion-pound investment in testing facilities at Porton Down in Wiltshire, announced by Health Secretary Matt Hancock last night.
The £29m funding boost will allow the facility to “significantly expand” the number of blood samples it can analyse for antibodies from 700 a week to 3,000, speeding up testing for possible new vaccines and booster jabs.
Professor Neil Ferguson, a former government adviser on coronavirus, told the BBC last night that the UK looks to be on a “steady course out of the pandemic” thanks to the vaccine rollout, with more than 34.6 million people in Britain having received at least a first dose.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Sorcha Bradley is a writer at The Week and a regular on “The Week Unwrapped” podcast. She worked at The Week magazine for a year and a half before taking up her current role with the digital team, where she mostly covers UK current affairs and politics. Before joining The Week, Sorcha worked at slow-news start-up Tortoise Media. She has also written for Sky News, The Sunday Times, the London Evening Standard and Grazia magazine, among other publications. She has a master’s in newspaper journalism from City, University of London, where she specialised in political journalism.
-
5 ways to help the environment while on vacation
The Week Recommends An afternoon of planting trees could be the best part of your trip
By Catherine Garcia, The Week US Published
-
Doctors are taking on dental duties in low-income areas
Under the radar Physicians are biting into the dentistry industry
By Devika Rao, The Week US Published
-
Instagram hopes that blurring nudity in messages will make teens safer
The Explainer The option will be turned on by default for users under 18
By Justin Klawans, The Week US Published
-
Covid four years on: have we got over the pandemic?
Today's Big Question Brits suffering from both lockdown nostalgia and collective trauma that refuses to go away
By Chas Newkey-Burden, The Week UK Published
-
How happy is Finland really?
Today's Big Question Nordic nation tops global happiness survey for seventh year in a row with 'focus on contentment over joy'
By Harriet Marsden, The Week UK Published
-
The hollow classroom
Opinion Remote school let kids down. It will take much more than extra tutoring for kids to recover.
By Mark Gimein Published
-
Excess screen time is making children only see what is in front of them
Under the radar The future is looking blurry. And very nearsighted.
By Devika Rao, The Week US Published
-
Covid-19: what to know about UK's new Juno and Pirola variants
in depth Rapidly spreading new JN.1 strain is 'yet another reminder that the pandemic is far from over'
By Arion McNicoll, The Week UK Published
-
Does declining birth rate spell doom for Britain?
Today's Big Question Ageing population puts pressure on welfare state, economy and fabric of society, while fertility is rising on populist agendas
By Harriet Marsden, The Week UK Published
-
Long-term respiratory illness is here to stay
The Explainer Covid is not the only disease with a long version
By Devika Rao, The Week US Published
-
Covid inquiry: the most important questions for Boris Johnson
Talking Point Former PM has faced weeks of heavy criticism from former colleagues at the public hearing
By The Week Staff Published